Value of serum cancer antigen12-5 level in diagnosis of peritoneal effusion in patients with liver cirrhosis

Zhang Hui; Jia Lei; Lu: Dong; Xu YouQing

doi:10.3969/j.issn.1001-5256.2016.11.022

Issue 11

Nov. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(11): 2118-2120

PDF( 1605 KB)

Value of serum cancer antigen12-5 level in diagnosis of peritoneal effusion in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2016.11.022

Research funding:

Published Date: 2016-11-20

Abstract

Abstract

Objective To investigate the value of serum cancer antigen 12- 5( CA12- 5) level in the diagnosis of peritoneal effusion in patients with liver cirrhosis. Methods A total of 142 patients with liver cirrhosis who were hospitalized at Beijing Tiantan hospital from January 2011 to December 2015 and met the inclusion criteria were enrolled. According to the presence or absence of peritoneal effusion,the patients were divided into peritoneal effusion group( 81 patients) and non- peritoneal effusion group( 61 patients). The two- independent-samples t test was used for comparison of normally distributed continuous data between groups,the Mann- Whitney U non- parametric test was used for comparison of non- normally distributed continuous data between groups,and the chi- square test was used for comparison of categorical data between groups. A Spearman correlation analysis was used to investigate the correlation between serum CA12- 5 level and the degree of peritoneal effusion. Results The peritoneal effusion group had a significantly higher serum CA12- 5 level than the non- peritoneal effusion group [290. 00( 50. 82- 618. 4) U / ml vs 15. 39( 9. 77- 23. 04) U / ml,Z =- 8. 537,P < 0. 01]. Serum CA12- 5 level was positively correlated with the degree of peritoneal effusion( r = 0. 812,P < 0. 01) and had a high diagnostic value for peritoneal effusion( the area under the receiver operating characteristic curve was 0. 92). Serum CA12- 5 level had a sensitivity of 81. 5% and a specificity of 88. 5%at a cut- off value of 35. 00 U / ml. Conclusion Serum CA12- 5 level can help with the diagnosis and monitoring of peritoneal effusion.
- liver cirrosis,
- CA12-5 antigen,
- diagnosis

FullText(HTML)

References(7)

References

[1]BOTTONI P,SCATENA R.The role of CA 125 as tumor marker:biochemical and clinical aspects[J].Adv Exp Med Biol,2015,867:229-244.

[2]HUANG XM,QIU JG,HONG RK,et al.Correlation analysis of serum CA125 level between Child-Pugh classification,CHE and volume of ascites in patients with cirrhosis[J].J Hepatopancreatobiliary Surg,2016,28(1):13-16.(in Chinese)黄喜岷,邱建国,洪睿珂,等.肝硬化患者血清CA125水平与Child-Pugh分级、CHE及腹水量相关性分析[J].肝胆胰外科杂志,2016,28(1):13-16.

[3]SCHUPPAN D,AFDHAL NH.Liver cirrhosis[J].Lancet,2008,371(9615):838-851.

[4]European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J].J Hepatol,2010,53(3):397-417.

[5]HUANG XD,WANG ZQ,XU Z,et al.Importance of detecting cancer antigen 125 in patients with liver cirrhosis with ascites[J].J Clin Hepatol,2003,19(3):143-144.(in Chinese)黄晓东,王子强,徐章,等.癌相关抗原125对慢性肝病合并腹水的诊断价值[J].临床肝胆病杂志,2003,19(3):143-144.

[6]QURESHI MO,DAR FS,KHOKHAR N.Cancer antigen-125 as a marker of ascites in patients with liver cirrhosis[J].J Coll Physicians Surg Pak,2014,24(232):5.

[7]CHOWDHURY MA,XIUBIN Z,WEI H,et al.Cancer antigen-125 and ICAM-1 are together responsible for ascites in liver cirrhosis[J].Clin Lab,2013,60(4):653-658.

Relative Articles

[1]	Yu ZHANG, Yongfeng YANG. Thinking of the pathological diagnosis of unexplained liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(3): 498-503. doi: 10.3969/j.issn.1001-5256.2023.03.003
[2]	Xixuan WANG, Liangzi DING, Yang CHENG, Hao HAN, Jian YANG, Jiangqiang XIAO, Yi WANG, Ming ZHANG, Feng ZHANG, Yuzheng ZHUGE. Value of liver stiffness measured by acoustic radiation force impulse in diagnosis of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2022, 38(11): 2488-2492. doi: 10.3969/j.issn.1001-5256.2022.11.010
[3]	Jialing ZHOU, Bingqiong WANG, Yameng SUN, Tongtong MENG, Shanshan WU, Hong MA, Xiaojuan OU, Hong YOU, Jidong JIA, Xiaoning WU. Application value of liver stiffness measurement-to-platelet ratio index score in diagnosis of hepatitis B liver fibrosis and liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1529-1533. doi: 10.3969/j.issn.1001-5256.2022.07.014
[4]	Zhongjie YU, Wenxia ZHAO, Leixin FENG, Hanxiao WANG, Jianpeng LIU. Value of five noninvasive diagnostic methods for liver cirrhosis in diagnosis of traditional Chinese medicine syndrome types in patients with compensated hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(1): 104-109. doi: 10.3969/j.issn.1001-5256.2022.01.016
[5]	Yajie XU, Wenzheng YOU, Wanlei REN, Quanhe LONG, Xiangjun JIANG, Doudou HU. Application of pathological indicators based on liver biopsy in the diagnosis of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2021, 37(12): 2935-2938. doi: 10.3969/j.issn.1001-5256.2021.12.042
[6]	Yu WANG, Min WANG, Guanhua ZHANG, Fuliang HE, Xiaojuan OU, Jidong JIA. Clinical diagnosis, staging, and therapeutic principles of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 17-21. doi: 10.3969/j.issn.1001-5256.2021.01.004
[7]	Xinlan ZHOU, Yanbing WANG, Wei LU, Xiufang LI, Dan HUANG, Zhanqing ZHANG, Rongrong DING. Value of five noninvasive serum models in the diagnosis of chronic hepatitis B liver fibrosis[J]. Journal of Clinical Hepatology, 2021, 37(7): 1567-1571. doi: 10.3969/j.issn.1001-5256.2021.07.018
[8]	NIU XingJie, LIU ZhiHui, CUI FengMei, LIU YaoMin, WANG YanFei, ZHANG GuoMin, LIU JinXia. Value of peripheral blood long non-coding RNA-LET in the diagnosis of chronic hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(12): 2709-2713. doi: 10.3969/j.issn.1001-5256.2020.12.014
[9]	Zhou ShengYun, Duan ZhiHui. Noninvasive diagnosis of esophageal varices in liver cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1842-1846. doi: 10.3969/j.issn.1001-5256.2020.08.036
[10]	Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and therapy of hepatic fibrosis(2019)[J]. Journal of Clinical Hepatology, 2019, 35(10): 2163-2172. doi: 10.3969/j.issn.1001-5256.2019.10.007
[11]	Li JiaNa, Zheng RuiQi, Li Na, Hu YuLin. The biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1361-1364. doi: 10.3969/j.issn.1001-5256.2019.06.040
[12]	Zhang YaNan, Jiang Chang, Xu Ying, Gao YanHang. Early diagnosis of spontaneous bacterial peritonitis in liver cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(8): 1851-1853. doi: 10.3969/j.issn.1001-5256.2019.08.045
[13]	Liu HaiFeng, Xu YongSheng, Zhang Yue, Zhao XiaoJu, Liu Zhao, Li JinKui, Yan RuiFeng, Xu Kai, Lei JunQiang. Value of magnetic resonance morphological imaging in the diagnosis and differentiation of post-hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(12): 2587-2591. doi: 10.3969/j.issn.1001-5256.2018.12.016
[14]	Yang ErNa, Cao WuKui. Research advances in noninvasive diagnosis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2209-2213. doi: 10.3969/j.issn.1001-5256.2017.11.035
[15]	Li JiaYan, Song JinYun, Wang JianFang, Wu XuPing. Value of combined detection of AFP, CA19-9, and CEA in early diagnosis of primary liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(7): 1291-1295. doi: 10.3969/j.issn.1001-5256.2017.07.017
[16]	Deng Han, Qi XingShun, Zhu Qiang, Guo XiaoZhong. Alternative methods for diagnosis of esophageal varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(8): 1468-1473. doi: 10.3969/j.issn.1001-5256.2016.08.007
[17]	Zhao Wei. Clinical significance of plasma and urine neutrophil gelatinase-associated lipocalin levels in diagnosis of acute kindney injury in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1874-1877. doi: 10.3969/j.issn.1001-5256.2015.11.025
[18]	Wang Shuai, Hu DaRong. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites[J]. Journal of Clinical Hepatology, 2015, 31(7): 1018-1022. doi: 10.3969/j.issn.1001-5256.2015.07.005
[19]	Cai JunJun, Han Tao. Diagnosis and treatment of acute kidney injury in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1352-1356. doi: 10.3969/j.issn.1001-5256.2014.12.030
[20]	Jia KeDong, Shi ShuXian, Ruan YouBing. Detection of sialic acid in hepatitis involved liver cirrhosis and its significance for HCC diagnosis[J]. Journal of Clinical Hepatology, 2005, 21(2): 101-103.

Supplements(0)

Cited By

Cited by
Periodical cited type(1)
1. 吴昳，李兆勇. 肝硬化患者中血清CA125检测的临床意义. 吉林医学. 2018(05): 956-958 .
Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2193) PDF downloads(468)

Value of serum cancer antigen12-5 level in diagnosis of peritoneal effusion in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2016.11.022

Abstract

References

Relative Articles

Cited by

Periodical cited type(1)

Other cited types(1)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Value of serum cancer antigen12-5 level in diagnosis of peritoneal effusion in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2016.11.022

Abstract

References

Relative Articles

Cited by

Periodical cited type(1)

Other cited types(1)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content